Literature DB >> 3298416

Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B hepatic viral antigen display.

J A McDonald, S Harris, J A Waters, H C Thomas.   

Abstract

Immunofluorescent and immunoperoxidase monoclonal antibody-based techniques were used to demonstrate hepatitis B e antigen (HBeAg) and hepatitis B c antigen (HBcAg) display in the liver biopsy specimens of 45 chronic hepatitis B virus (HBV) carriers. Anti-human immunodeficiency virus (anti-HIV)-positive HBV carriers had many more HBe- and HBc-positive hepatocyte nuclei than anti-HIV-negative carriers (P less than 0.0003 and less than 0.02, respectively), and HBV-DNA levels were slightly, but not significantly, increased in the positive subjects. The number of HBe- and HBc-positive nuclei were positively correlated with serum HBV-DNA levels (P less than 0.05 comparing high serum HBV-DNA levels of greater than 2880 pg/ml and levels of 1-480 pg/ml), and were negatively correlated with disease activity (P less than 0.05 comparing those with severe chronic active hepatitis (CAH) and those with mild CAH and chronic persistent hepatitis (CPH]. These results indicate that male homosexual HBV carriers, positive for anti-HIV, may be immunosuppressed before there are clinical signs of immunodeficiency, and this allows an increased level of replication of at least one other virus (HBV).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3298416     DOI: 10.1016/s0168-8278(87)80543-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Seroconversion to HBV associated with seroconversion to HIV in a cohort of intravenous drug misusers in Turin, Italy.

Authors:  A Sinicco; R Fora; M Sciandra; R Raiteri
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

2.  Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.

Authors:  M G Brook; G Chan; I Yap; P Karayiannis; A M Lever; M Jacyna; J Main; H C Thomas
Journal:  BMJ       Date:  1989-09-09

3.  HIV through the looking glass: insights derived from Hepatitis B.

Authors:  Maria M Rivera; Alejandro Soza; Alison Jazwinski; Lijun Mi; David E Kleiner; Xiongce Zhao; Charma Zuber; Douglas Brust; Emory Hsu; Jennifer Simpson; Jay H Hoofnagle; Theo Heller
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-01       Impact factor: 3.731

Review 4.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

5.  Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection.

Authors:  R D Goldin; D E Fish; A Hay; J A Waters; M J McGarvey; J Main; H C Thomas
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

6.  Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients.

Authors:  D Francisci; F Baldelli; R Papili; G Stagni; S Pauluzzi
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.